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Dear Dr. Hopper, 
It is with pleasure that I transmit to you, as I agreed 
at the Group’s mid-term meeting in Berlin, the position paper 
prepared by TAC entitled “The Role of Biotechnology in the 
CGIAR” . This paper is substantially the statement presented by 
TAC at Berlin and endorsed by the Group. It has however been 
ecllarged somewhat, to cover additional points and concerns 
raised during the discussion. 
It is TAC’s considered opinion that this document will 
serve to guide the Centres in the responsible use of 
biotechnology. In addit ion it should encourage an increase in 
collaborative research between the Centces and specialized 
academic and private sector institutions. This should be of 
considerable benefit to agriculture in the developing world. 
Sincerely, 
Alex F. McCal la 
TAC Cha i rman 
Dr. W. David Hopper 
Chairman, CGIAR 
World Bank 
1818 H Street, N.W. 
Washington D.C. 20433 
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THE ROLE OF BIOTECHNOLOGY IN THE CGIAR 
Introduction 
'The study of practical applications of discoveries in the 
biological sciences has become widely known as "biotechnology". The 
term is used in such widely different contexts, however, that it is 
often misinterpreted. For this reason, TAC has used the term only 
sparingly in its analyses of research programmes and strategies. 
Nonetheless TAC has implicitly included advances in biotechnology in 
more general expressions, such as "strategic research", "upstream 
research" and "collaborative research with advanced institutions". 
The growing interest in biotechnology, however, especially by 
donors and policy-makers, has made it desirable for TAC to be more 
explicit. This paper summarizes the opinions already expressed by TAC 
on issues related to biotechnology, describes further studies in 
progress and highlights those issues that need to be kept under review. 
Maintaining an Awareness of New Opportunities 
The rapid rate at which new knowledge is emerging from the 
biological sciences makes it essential for all concerned, both in the 
industrialized and the developing countries, to have continuous access 
to informed opinions on its potential applications. For the future 
success of agricultural research, it is not just the individual 
scientists who must keep in touch with new applications, but planners 
and policy-makers as well. TAC is in a position to make informed 
judgements on the role of biotechnology in research supported by the 
CGIAR through the expertise of its individual members, the linkages its 
memblnrs have with advanced institutions throughout the world, and 
through reports of its review panels and consultants. Its primary 
responsibility is to recommend strategies to the CGIAR that will 
optimize returns from investment in research in relation to the Group's 
accepted goals. 
TAC's collective judgement is no substitute, however, for the 
Centres' own capacity to monitor developments in biotechnology. Only in 
this way can they identify those innovations most likely to benefit 
their own research, as well as fulfil their responsibility to help 
national programmes to maintain an awareness of new possibilities. To 
meet these needs, TAC has urged Centres to establish linkages with 
advanced institutions in order to take advantage of advances in 
biotechnology and has encouraged them to strengthen their expertise in 
biotechnology through training and recruitment in order that new 
opportunities should not be missed (1). 
The scope of biotechnology is so wide that individual Centres 
could never be expected to cover more than a tiny fraction of the whole 
subject. Consequently, basic education in the relevant biological 
sciences must clearly remain a responsibility of the universities. The 
training offered by Centres must continue to be targeted to specific 
areas related to their mandated activities. 
TAC, the CGLAR, the Centres and other international 
organizations can all contribute to creating a more informed climate of 
opinion on matters relating to biotechnology. Planners and policy- 
makers must be alerted both to the realistic opportunities for applying 
biotechnology to the problems of developing countries as well as to the 
attendant constraints and costs. Two recent symposia have been helpful 
in this respect. One, organized by IRRI in October 1986, concentrated 
on rice. The other, organized by COSTED and CASAFA in December 1987, 
covered all agricultural applications of biotechnology (2). Both 
symposia were designed to bring senior administrators and planners in 
the developing countries into contact with leading research workers 
involved in the application of new biological techniques to problems in 
agricultural research. Both stressed the need for training, especially 
of the older scientists to enable them to interact more effectively with 
younger scientists trained in the new techniques as part of their 
university education. They also recognized the need for these younger 
scientists to widen their perceptions through close interaction with 
practising plant breeders and animal production specialists. 
The transfer of alien genes into plants carries with it the 
risk of changing the nutritional quality of food derived from them 
perhaps in ways that might be harmful. Moreover, some genetic 
transformations might have harmful effects on the environment. For 
example, the transformation of crop plants to produce toxins to insect 
pests might disturb the ecological balance of natural insect 
populations, with adverse effects on the natural enemies of a wider 
spectrum of crop pests. 
TAC and the Centres have an obligation to maintain an awareness 
of p-roblems of this type and to monitor the development of guidelines 
and regulations related to them. It is especially important that the 
Centres should strictly observe accepted codes of practice in all 
activities related to molecular biology and genetic engineering. 
Consideration must also be given to the socio-economic 
implications for developing countries of changes induced through 
adoption of the products of biotechnology. It is possible that some 
innovations might serve to widen the gap between resource-poor farmers 
and those with access to industrial products as might happen, for 
example, with the introduction of varieties resistant to specific 
herbicides. 
Equally, other innovations, such as the incorporation of novel 
forms of virus resistance, might be of greatest benefit to the poorest 
farmers. Difficult policy choices have to be made, both with respect to 
the promotion of the products of biotechnology and to the extent of 
investment in research in any particular aspect. Topics such as these, 
sllould progressively be illcclrporated into socio-economic research in the 
System. 
The :System's Capacity for Biotechnological Research 
Although all the Centres involved in biological research have 
invested in the products of biotechnology to a greater or lesser extent, 
the (question is frequently asked whether they are responding rapidly 
enough to new opportunities. In this connection various suggestions 
have been made, such as the creation of a special CGIAR fund to support 
biotechnological research or the funding of a special laboratory for 
such work within the CGIAR family (3). 
TAC's view is that research supported by the CGIAR should 
continue to be orientated towards the solution of problems, rather than 
towards the pursuit of new knowledge or the development of new research 
tools per se. TAC considers that a special CGIAR fund for biotechnology -- 
would tend to highlight the techniques rather than the problems. The 
Committee therefore suggests that biotechnology at the Centres should 
continue to be funded through the normal processes of priority setting 
and resource allocation. For similar reasons, TAC considers that 
investment in a new laboratory staffed by specialists would not 
represent the most cost-effective use of CGIAR funds (4). 
In reaching this conclusion, TAC recognized the opportunities 
that already exist for the bilateral funding of collaborative programmes 
between Centres and advanced institutions, such as those discussed at 
the CGIAR Symposium at Bad Homburg, Fed. Rep. of Germany, 17-22 August 
1986 (5). These collaborative arrangements are well suited to meet the 
main needs of the Centres for strategic research in biotechnology for 
the foreseeable future. 
In general, the modification of technological innovations for 
application to specific problems is best done collaboratively between 
the scientists attempting to solve the problems and those involved in 
the appropriate areas of fundamental or strategic research. It would be 
prohibitively expensive for the Centres individually, or for the CGIAR 
to acquire, through a new central laboratory, all the facilities and 
expertise required to tackle such a diversity of relevant aspects of 
biotechnology as are likely to arise during the coming decade. TAC 
therefore considers that it would be a more efficient use of CGIAR 
resources for the Centres to continue to develop contractual or 
collaborative arrangements with the institutions best suited to tackle 
the particular problem. 
A good example of the advantages of such arrangements is 
provided by the recent success of a collaborative programme initiated by 
IRRI for the modification of techniques of protoplast regeneration for 
specific application to rice. Indeed, IRRI has extended its 
collaboration with advanced institutions as part of an informal 
international network to further the application of molecular genetics 
and cell biology to rice improvement. Similarly, CIMMYT is 
participating in a networking approach to the application of recombinant 
DNA techniques to gene-mapping in maize. All such arrangements have the 
adva.ntage of enablirlg the Centres to Jraw up011 tile full support of major 
institutions in ways that it would be extremely costly to duplicate. 
The CGIAR Secretariat has recently produced a review of these and other 
aspects of the Centres' work on biotechnology (6). 
The role of the Centres should be to evaluate new applications 
of biological science and assess their potential cost-eEfectiveness in 
helping to solve carefully identified problems of high priority. They 
should continue to develop the facilities required for the routine 
application of biotechnological innovations, once these become available 
as a result of their collaborative research. They should also be in a 
position to assist developing countries, through training, to do 
likewise. In this way, they will help to bridge the gap between the 
capabilities of advanced institutions and the needs of programmes of 
applied agricultural research in the developing countries. No single 
formula is likely to be appropriate for all Centres for these purposes, 
however, either with respect to the size of the required facilities or 
to the composition of staff. The determining factors should relate 
primarily to the nature of the problems to be solved, but also to 
considerations such as the opportunities for collaboration. 
TAC has consistently supported the Centres in initiatives that 
conform to these general principles, both in its routine reviews of 
programmes and budgets, and in its comments on strategic plans. More 
generally, however, in recognizing concerns that the Centres might lack 
the capability of exploiting opportunities arising from research in 
molecular and cell biology, TAC has advocated that the CGIAR should be 
high:Ly selective in its support for research in these areas. The field 
is enormous and the System must concentrate its effort on carefully 
selected problems of high priority if it is to be successful in 
exploiting those applications most likely to help in the solution of 
problems related to the productivity of crops and livestock (7). 
This principle also applies to the work of ILRAD where TAC has 
supported investment in biotechnology at a level that is exceptionally 
high for CGIAK institutions. ILRAD was created to investigate highly 
specialized problems from the outset and its scientists have been at the 
forefront of biotechnological research related to two major animal 
diseases. For example, recombinant DNA techniques are used by ILRAD 
scientists to synthesize the antigens needed for research on the immune 
response. Even so, ILRAD recognizes that it cannot cover all relevant 
aspects of research in the depth required. Accordingly, it also 
exploits opportunities for collaborative research whenever appropriate. 
Relationships with the Private Sector 
Commercial investment in biotechnology raises questions about 
future relationships between the Centres and research institutions in 
the private sector. In many instances, private sector involvement will 
be seen as complementary to Centre activities. For example, the private 
sector is already heavily involved in the development and supply of 
numerous products resulting from biotechnology, such as the molecular 
products required in research programmes, improved rhizobial 
formulations for the inoculation of leguminous crops and pharmaceutical 
products for animal health. 
TAC regards collaboration with the private sector as an 
important topic which it will keep under review. A TAC sub-committee is 
currently conducting a study of this subject with a view to analyzing 
the areas of potential cooperation likely to prove most fruitful for the 
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Centres. It will also be desirable to identify areas where private 
sector activities might restrict the freedom of action of the Centres, 
or restrict the benefits that developing countries might otherwise 
derive from new opportunities. 
In this context, the most commonly expressed concerns relate to 
the genetic manipulation of plants and possible restrictions on the 
availability of useful genetic material through the application of 
patents or other forms of property rights. TAC discussed this topic 
extensively in 1981 and 1982. The position adopted by the Committee 
then (8) will shortly be reviewed by the proposed joint TAC/Centre 
Directors working group on genetic resources (4). If, in the light of 
recent developments, the statement is no longer considered adequate as a 
basis for CGIAR policy, then TAC will issue a revised statement. 
The Opportunity Cost of Biotechnological Research 
Because of the unpredictable outcome of research, investment in 
any one approach carries with it an opportunity cost represented by the 
probability of greater success from an alternative approach. In current 
research on crop improvement, for example, controversy has been created 
by the difficulties of assessing the relative costs and benefits of 
radical new approaches to genetic manipulation compared with well 
esta'olished methods. In general, TAC has cautioned against undue 
involvement by the Centres in high-risk research, especially when there 
are no indications that the possibilities for further advances along 
established lines are reaching the point of exhaustion and when the 
needs for good applied research in the developing countries are still of 
paramount importance. 
There are dangers, however, both that exaggerated claims for 
the potential impact of biotechnological innovations will give rise to 
unrealistic expectations and that summary rejection of such claims will 
result in under-exploitation of real opportunities. TAC and Centre 
Boards carry major responsibilities in these respects. While TAC has 
fully recognized the role of biotechnology in agricultural research, it 
has also kept in mind the nature and magnitude of the problems posed by 
the challenge to achieve sustainable agricultural production in the 
developing countries. What, for example, are the prospects of 
genetically engineering drought resistance in crop plants compared with 
the prospects of increasing production in drought-prone areas through 
the more efficient use of rainfall? Striking an appropriate balance 
between widely different approaches of this type will continue to guide 
TAC's advice to the Group on the efficient use of the System's 
resources. 
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